JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2024  1,200
2023  1,500
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 60(2026) N 1 p. 120-139; DOI 10.1134/S002689332570061X Full Text

I.D. Goncharov1, A.A. Alekseev1*, N.E. Morozova1, A.I. Sadova1, M.A. Khodorkovskii1

Functional and Structural Features of RecA and RAD51 Recombinases in the Contexts of Antibiotic Resistance of Pathogenic Bacteria and Therapy of Cancer

1Peter the Great St. Petersburg Polytechnic University, St. Petersburg, 195251 Russia

*alex35093@gmail.com
Received - 2025-05-12; Revised - 2025-07-31; Accepted - 2025-08-04

The RecA and RAD51 proteins are pivotal enzymes in homologous recombination in bacteria and eukaryotic cells. The proteins, organized into nucleoprotein filaments, mediate precise repair of severe DNA damage, and this repair is essential for maintaining genome stability. Investigating the structures, functions, and regulatory mechanisms of RecA and RAD51 holds significant practical importance. Dysregulation of human recombinase RAD51 has been implicated in various oncological diseases. RAD51 overexpression is frequently observed in malignant tumors and correlates with their drug resistance, underscoring the urgent need for the development of RAD51 inhibitors. In bacteria, RecA activates the SOS response and SOS-induced mutagenesis and participates in horizontal gene transfer, that is, processes directly linked to the emergence and dissemination of antibiotic resistance genes. The global spread of bacterial resistance poses a major challenge worldwide. A potential strategy to address this issue is identifying and developing RecA inhibitors for use in adjuvant therapies aimed at suppressing the mechanisms of bacterial adaptation to antibiotics. This review explores the structural and functional characteristics of the RecA and RAD51 proteins and the nucleoprotein filaments they form. Their roles in recombination repair are considered along with the mechanisms governing their regulation. Furthermore, approaches to inhibition of RecA and RAD51 activities are discussed with a focus on their practical applications.

RecA, RAD51, homologous recombination, SOS response, antibiotic resistance, cancer therapy, inhibitors



JMB-FOOTER RAS-JOURNALS